TuHURA Biosciences (HURA) Treasury Shares (2010 - 2024)
TuHURA Biosciences (HURA) posted quarterly Treasury Shares of $13668.0 for Q1 2024, down 3.8% year-over-year from $14208.0 in Q2 2023, and little changed quarter-over-quarter from $13668.0 in Q4 2023.
TuHURA Biosciences (HURA) Treasury Shares (2010 - 2024) Analysis & Trends
TuHURA Biosciences' Treasury Shares history runs 6 years deep, the most recent figure standing at $13668.0 for Q1 2024.
- In Q1 2024, Treasury Shares fell 3.8% year-over-year to $13668.0; the TTM figure through Mar 2024 stood at $13668.0 (down 3.8% YoY), while the FY2023 annual figure was $13668.0, changed N/A from the prior year.
- Treasury Shares for Q1 2024 stood at $13668.0, roughly flat from $13668.0 in the prior quarter.
- The five-year high for Treasury Shares was $20.1 million in Q2 2021, with the low at $13668.0 in Q4 2023.
- The 5-year median for Treasury Shares is $16838.0 (2022), against an average of $1.6 million.
- The sharpest annual moves came in 2021 and 2024: Treasury Shares retreated 27.43% in 2021, then declined 3.8% in 2024.
- TuHURA Biosciences' Treasury Shares stood at $23670.0 in 2020, then declined by 27.43% to $17177.0 in 2021, then retreated by 16.24% to $14388.0 in 2022, then dropped by 5.0% to $13668.0 in 2023, then changed by 0.0% to $13668.0 in 2024.
- Business Quant data shows HURA's Treasury Shares at $13668.0 in Q1 2024, $13668.0 in Q4 2023, and $14158.0 in Q3 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 8.96 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 2.72 Mn |
| 10 | TuHURA Biosciences | 37.61 Mn | 37.61 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 13,668.00 |
| Mar 31, 2024 | 13,668.00 |
| Dec 31, 2023 | 13,668.00 |
| Dec 31, 2023 | 13,668.00 |
| Sep 30, 2023 | 14,158.00 |
| Sep 30, 2023 | 14,158.00 |
| Mar 31, 2023 | 14,208.00 |
| Mar 31, 2023 | 14,208.00 |
| Dec 31, 2022 | 14,388.00 |
| Dec 31, 2022 | 14,388.00 |
| Sep 30, 2022 | 16,838.00 |
| Sep 30, 2022 | 16,838.00 |
| Mar 31, 2022 | 16,838.00 |
| Mar 31, 2022 | 16,838.00 |
| Dec 31, 2021 | 17,177.00 |
| Dec 31, 2021 | 17,177.00 |
| Sep 30, 2021 | 18,382.00 |
| Sep 30, 2021 | 18,382.00 |
| Jun 30, 2021 | 20.09 Mn |
| Jun 30, 2021 | 20.09 Mn |